Cargando…

Clinical manifestations and pathological correlation of immunoglobulin A nephropathy in children

BACKGROUND: IgA nephropathy in children has various clinical manifestations. Kidney biopsy is a gold standard for diagnosis by using Oxford classification 2016 with few studies about the correlation between clinical and pathology manifestations. This study aims to find these correlations at the time...

Descripción completa

Detalles Bibliográficos
Autores principales: Sausukpaiboon, Karnchanit, Panombualert, Sunee, Wisanuyotin, Suwannee, Puapairoj, Anucha, Suparattanagool, Piyanan, Techasatian, Leelawadee, Tantawarak, Nattakarn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667660/
https://www.ncbi.nlm.nih.gov/pubmed/36384494
http://dx.doi.org/10.1186/s12882-022-03002-3
_version_ 1784831766021799936
author Sausukpaiboon, Karnchanit
Panombualert, Sunee
Wisanuyotin, Suwannee
Puapairoj, Anucha
Suparattanagool, Piyanan
Techasatian, Leelawadee
Tantawarak, Nattakarn
author_facet Sausukpaiboon, Karnchanit
Panombualert, Sunee
Wisanuyotin, Suwannee
Puapairoj, Anucha
Suparattanagool, Piyanan
Techasatian, Leelawadee
Tantawarak, Nattakarn
author_sort Sausukpaiboon, Karnchanit
collection PubMed
description BACKGROUND: IgA nephropathy in children has various clinical manifestations. Kidney biopsy is a gold standard for diagnosis by using Oxford classification 2016 with few studies about the correlation between clinical and pathology manifestations. This study aims to find these correlations at the time of diagnosis and during short-term follow-up. METHOD: In this retrospective cohort study, 47 pediatric patients who underwent renal biopsy from 2010 to 2021 in Thailand, were included. Oxford classification 2016 has been used to score patients’ pathology. Univariate and multivariate associations have been used for correlation between clinical and pathologic parameters. RESULTS: The most common clinical manifestations were microscopic hematuria and proteinuria. There were 68% of children with mesangial hypercellularity (M1), 42% with segmental glomerulosclerosis (S1), 25% with moderate to severe crescent (C1/C2), 23% with endocapillary hypercellularity (E1), and 14% with moderate to a severe tubular atrophy/interstitial fibrosis (T1/T2). Microscopic hematuria was strongly associated with mesangial hypercellularity (M1) OR 7.14 (95%CI 1.83 – 27.88, p-value 0.005) and hypertension was strongly associated with segmental glomerulosclerosis (S1) adjusted OR 7.87 (95%CI 1.65 – 37.59, p-value 0.01). Intensive treatment was used more in the patients with tubular atrophy/interstitial fibrosis lesion on renal biopsy than other lesions from MEST-C scores OR 4.98 (95%CI 1.17–21.24, p-value 0.03). Furthermore, pulse methylprednisolone and cyclophosphamide were used in patients with crescentic lesions significantly than other lesions with OR 15.5 (95%CI 3.16- 75.93, p-value 0.001) and OR 5.75 (95%CI 1.31–25.29, p-value 0.021), respectively. CONCLUSION: Tubular atrophy/interstitial fibrosis and crescent lesions were correlated to intensive treatment in short-term outcomes.
format Online
Article
Text
id pubmed-9667660
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96676602022-11-17 Clinical manifestations and pathological correlation of immunoglobulin A nephropathy in children Sausukpaiboon, Karnchanit Panombualert, Sunee Wisanuyotin, Suwannee Puapairoj, Anucha Suparattanagool, Piyanan Techasatian, Leelawadee Tantawarak, Nattakarn BMC Nephrol Research BACKGROUND: IgA nephropathy in children has various clinical manifestations. Kidney biopsy is a gold standard for diagnosis by using Oxford classification 2016 with few studies about the correlation between clinical and pathology manifestations. This study aims to find these correlations at the time of diagnosis and during short-term follow-up. METHOD: In this retrospective cohort study, 47 pediatric patients who underwent renal biopsy from 2010 to 2021 in Thailand, were included. Oxford classification 2016 has been used to score patients’ pathology. Univariate and multivariate associations have been used for correlation between clinical and pathologic parameters. RESULTS: The most common clinical manifestations were microscopic hematuria and proteinuria. There were 68% of children with mesangial hypercellularity (M1), 42% with segmental glomerulosclerosis (S1), 25% with moderate to severe crescent (C1/C2), 23% with endocapillary hypercellularity (E1), and 14% with moderate to a severe tubular atrophy/interstitial fibrosis (T1/T2). Microscopic hematuria was strongly associated with mesangial hypercellularity (M1) OR 7.14 (95%CI 1.83 – 27.88, p-value 0.005) and hypertension was strongly associated with segmental glomerulosclerosis (S1) adjusted OR 7.87 (95%CI 1.65 – 37.59, p-value 0.01). Intensive treatment was used more in the patients with tubular atrophy/interstitial fibrosis lesion on renal biopsy than other lesions from MEST-C scores OR 4.98 (95%CI 1.17–21.24, p-value 0.03). Furthermore, pulse methylprednisolone and cyclophosphamide were used in patients with crescentic lesions significantly than other lesions with OR 15.5 (95%CI 3.16- 75.93, p-value 0.001) and OR 5.75 (95%CI 1.31–25.29, p-value 0.021), respectively. CONCLUSION: Tubular atrophy/interstitial fibrosis and crescent lesions were correlated to intensive treatment in short-term outcomes. BioMed Central 2022-11-16 /pmc/articles/PMC9667660/ /pubmed/36384494 http://dx.doi.org/10.1186/s12882-022-03002-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Sausukpaiboon, Karnchanit
Panombualert, Sunee
Wisanuyotin, Suwannee
Puapairoj, Anucha
Suparattanagool, Piyanan
Techasatian, Leelawadee
Tantawarak, Nattakarn
Clinical manifestations and pathological correlation of immunoglobulin A nephropathy in children
title Clinical manifestations and pathological correlation of immunoglobulin A nephropathy in children
title_full Clinical manifestations and pathological correlation of immunoglobulin A nephropathy in children
title_fullStr Clinical manifestations and pathological correlation of immunoglobulin A nephropathy in children
title_full_unstemmed Clinical manifestations and pathological correlation of immunoglobulin A nephropathy in children
title_short Clinical manifestations and pathological correlation of immunoglobulin A nephropathy in children
title_sort clinical manifestations and pathological correlation of immunoglobulin a nephropathy in children
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667660/
https://www.ncbi.nlm.nih.gov/pubmed/36384494
http://dx.doi.org/10.1186/s12882-022-03002-3
work_keys_str_mv AT sausukpaiboonkarnchanit clinicalmanifestationsandpathologicalcorrelationofimmunoglobulinanephropathyinchildren
AT panombualertsunee clinicalmanifestationsandpathologicalcorrelationofimmunoglobulinanephropathyinchildren
AT wisanuyotinsuwannee clinicalmanifestationsandpathologicalcorrelationofimmunoglobulinanephropathyinchildren
AT puapairojanucha clinicalmanifestationsandpathologicalcorrelationofimmunoglobulinanephropathyinchildren
AT suparattanagoolpiyanan clinicalmanifestationsandpathologicalcorrelationofimmunoglobulinanephropathyinchildren
AT techasatianleelawadee clinicalmanifestationsandpathologicalcorrelationofimmunoglobulinanephropathyinchildren
AT tantawaraknattakarn clinicalmanifestationsandpathologicalcorrelationofimmunoglobulinanephropathyinchildren